Antimicrobial Resistance (AMR) Patient Conference 2026

Dr Christina Thornton is a respirologist and physician-scientist at the University of Calgary in Canada. In clinic, she cares for people living with bronchiectasis, nontuberculous mycobacterial (NTM) lung disease and cystic fibrosis, conditions in which chronic infection and antimicrobial resistance are a constant part of care. Her research lab studies the airway microbiome, chronic lung infection and antimicrobial resistance. She co-chairs the ERS AMR-Lung Clinical Research Collaboration, leads the Canadian Bronchiectasis and NTM Registry, and co-chairs both the CHEST and Canadian Thoracic Society bronchiectasis guidelines.

Efthymia Papadopoulou is a respiratory physician and clinical researcher based in Greece. As an active early-career member of the European Respiratory Society, she has contributed to several projects within the AMR-Lung Clinical Research Collaboration. Her work includes research on the impact of antimicrobial resistance in lung disease and collaboration with patient representatives to better understand patient experiences and priorities.

Dr Herbert Kwok is a Clinical Assistant Professor at The University of Hong Kong and a specialist in respiratory medicine. His research focuses on airway diseases, including asthma, bronchiectasis and chronic obstructive pulmonary disease (COPD), as well as lung cancer. He has received numerous awards for his research and education activities and is actively involved in advancing respiratory medicine across the Asia-Pacific region.

Tom Bermingham is a member of the European Lung Foundation's Aspergillosis Patient Advisory Group and lives in Wexford, Ireland. Following a diagnosis of aspergillosis, bronchiectasis and severe adult-onset asthma in 2022, he has become a passionate advocate for greater awareness of fungal lung disease and patient involvement in healthcare and research. His experience of long-term antibiotic and antifungal treatment has highlighted the growing impact of antimicrobial resistance on patients' lives.

Justine Hamaïde is a patient advocate from France living with bronchiectasis and nontuberculous mycobacterial (NTM) lung disease. She is President of the patient organisation MNT Mon Poumon Mon Air and a member of the European Lung Foundation Bronchiectasis Patient Advisory Group. Through her advocacy work, she supports people affected by NTM lung disease and promotes greater patient involvement in research, care and awareness activities.